Tag - biopharma

Celltrion on track to release world’s first flu-targeting therapeutic antibodies

Celltrion said Tuesday that it is on track to introduce the world’s first therapeutic antibody for the treatment of universal influenza, as the new drug will begin the second part of its phase II clinical trials by the end of this year. The South Korean biopharma company, best known for its biosimilar drugs that reference blockbuster biologic drugs like Remicade, is currently preparing its new influenza drug CT-P27 for phase II 2b trials. Celltrion said it has yet to determine where [...]

Read more...